RREB-1 is a transcriptional repressor of HLA-G

Journal of Immunology

Volumn 183, Issue 11, 2009, Pages 6948-6959

  Flajollet, Sébastien ^a   Poras, Isabelle ^a   Carosella, Edgardo D ^a   Moreau, Philippe ^a  

^a Inst Univ d'Hématologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; C TERMINAL BINDING PROTEIN 1; C TERMINAL BINDING PROTEIN 2; HISTONE DEACETYLASE 1; HLA G ANTIGEN; PROTEIN SUBUNIT; RAS RESPONSIVE ELEMENT ELEMENT BINDING PROTEIN 1; REPRESSOR PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA-G ANTIGEN; RREB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; BIOSYNTHESIS; CHROMATIN IMMUNOPRECIPITATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPIGENESIS, GENETIC; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 73349141408     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902053     Document Type: Article

References (67)

1. Carosella, E. D., B. Favier, N. Rouas-Freiss, P. Moreau, and J. Lemaoult. 2008. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 111: 4862-4870.
2. Apps, R., L. Gardner, and A. Moffett. 2008. A critical look at HLA-G. Trends Immunol. 29: 313-321.
3. Caumartin, J., B. Favier, M. Daouya, C. Guillard, P. Moreau, E. D. Carosella, and J. LeMaoult. 2007. Trogocytosis-based generation of suppressive NK cells. EMBO J. 26: 1423-1433.
4. LeMaoult, J., J. Caumartin, M. Daouya, B. Favier, S. Le Rond, A. Gonzalez, and E. D. Carosella. 2007. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 109: 2040-2048.
5. + T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Eur. J. Immunol. 34: 649-660.
6. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186: 1809-1818. (Pubitemid 27524591)
7. Colonna, M., J. Samaridis, M. Cella, L. Angman, R. L. Allen, C. A. O'Callaghan, R. Dunbar, G. S. Ogg, V. Cerundolo, and A. Rolink. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160: 3096-3100. (Pubitemid 28164696)
8. Rajagopalan, S., and E. O. Long. 1999. A human histocompatibility leucocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189: 1093-1099. (Pubitemid 29169826)
9. McMaster, M. T., C. L. Librach, Y. Zhou, K. H. Lim, M. J. Janatpour, R. DeMars, S. Kovats, C. Damsky, and S. J. Fisher. 1995. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J. Immunol. 154: 3771-3778.
10. Houlihan, J. M., P. A. Biro, H. M. Harper, H. J. Jenkinson, and C. H. Holmes. 1995. The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J. Immunol. 154: 5665-5674.
11. + dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int. Immunol. 11: 889-898.
12. Le Discorde, M., P. Moreau, P. Sabatier, J. M. Legeais, and E. D. Carosella. 2003. Expression of HLA-G in human cornea, an immune-privileged tissue. Hum. Immunol. 64: 1039-1044. (Pubitemid 37413712)
13. Cirulli, V., J. Zalatan, M. McMaster, R. Prinsen, D. R. Salomon, C. Ricordi, B. E. Torbett, P. Meda, and L. Crisa. 2006. The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 55: 1214-1222. (Pubitemid 44195357)
14. Menier, C., M. Rabreau, J. C. Challier, M. Le Discorde, E. D. Carosella, and N. Rouas-Freiss. 2004. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 104: 3153-3160. (Pubitemid 39507129)
15. Rouas-Freiss, N., P. Moreau, C. Menier, J. LeMaoult, and E. D. Carosella. 2007. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. Semin. Cancer Biol. 17: 413-421. (Pubitemid 350064561)
16. Rebmann, V., S. Wagner, and H. Grosse-Wilde. 2007. HLA-G expression in malignant melanoma. Semin. Cancer Biol. 17: 422-429.
17. low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 110: 3936-3948.
18. Carosella, E. D., P. Moreau, J. Lemaoult, and N. Rouas-Freiss. 2008. HLA-G: from biology to clinical benefits. Trends Immunol. 29: 125-132.
19. Onno, M., T. Guillaudeux, L. Amiot, I. Renard, B. Drenou, B. Hirel, M. Girr, G. Semana, P. Le Bouteiller, and R. Fauchet. 1994. The HLA-G gene is expressed at a low mRNA level in different human cells and tissues. Hum. Immunol. 41: 79-86. (Pubitemid 24319055)
20. Moreau, P., S. Lefebvre, L. Gourand, J. Dausset, E. D. Carosella, and P. Paul. 1998. Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver. Hum. Immunol. 59: 751-757. (Pubitemid 28512542)
21. Geraghty, D. E., B. H. Koller, and H. T. Orr. 1987. A human major histocompatibility complex class I gene that encodes a protein with shortened cytoplasmic segment. Proc. Natl. Acad. Sci. USA 84: 9145-9149.
22. Shukla, H., A. Swaroop, R. Srivastava, and S. M. Weissman. 1990. The mRNA of a human class I gene HLA G/HLA 6.0 exhibits a restricted pattern of expression. Nucleic Acids Res. 18: 2189. (Pubitemid 20171564)
23. Solier, C., V. Mallet, F. Lenfant, A. Bertrand, A. Huchenq, and P. Le Bouteiller. 2001. HLA-G unique promoter region: functional implications. Immunogenetics 53: 617-625. (Pubitemid 33152521)
24. Ishitani, A. G., D. E. 1992. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc. Natl. Acad. Sci. USA 89: 3947-3951.
25. Kirszenbaum, M., P. Moreau, E. Gluckman, J. Dausset, and E. Carosella. 1994. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc. Natl. Acad. Sci. USA 91: 4209-4213.
26. Paul, P., F. A. Cabestre, E. C. Ibrahim, S. Lefebvre, I. Khalil-Daher, G. Vazeux, R. M. Quiles, F. Bermond, J. Dausset, and E. D. Carosella. 2000. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum. Immunol. 61: 1138-1149.
27. van den Elsen, P. J., A. Peijnenburg, M. C. van Eggermond, and S. J. Gobin. 1998. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol. Today 19: 308-312. (Pubitemid 28322326)
28. Gobin, S. J., P. Biesta, J. E. de Steenwinkel, G. Datema, and P. J. van den Elsen. 2002. HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes. J. Biol. Chem. 277: 39525-39531.
29. Gobin, S. J., A. Peijnenburg, V. Keijsers, and P. J. van den Elsen. 1997. Site alpha is crucial for two routes of IFN γ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6: 601-611.
30. Gobin, S. J., and P. J. van den Elsen. 2000. Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. Hum. Immunol. 61: 1102-1107.
31. Rousseau, P., K. Masternak, M. Krawczyk, W. Reith, J. Dausset, E. D. Carosella, and P. Moreau. 2004. In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner. Immunology 111: 53-65.
32. Schmidt, C. M., R. G. Ehlenfeldt, M. C. Athanasiou, L. A. Duvick, H. Heinrichs, C. S. David, and H. T. Orr. 1993. Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice: evidence for a positive regulatory region located 1 kilobase 5′ to the start site of transcription. J. Immunol. 151: 2633-2645.
33. Schmidt, C. M., H. L. Chen, I. Chiu, R. G. Ehlenfeldt, J. S. Hunt, and H. T. Orr. 1995. Temporal and spatial expression of HLA-G messenger RNA in extraembryonic tissues of transgenic mice. J. Immunol. 155: 619-629.
34. Moreau, P., P. Paul, L. Gourand, S. Prost, J. Dausset, E. Carosella, and M. Kirszenbaum. 1997. HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1. Hum. Immunol. 52: 41-46.
35. Lefebvre, S., S. Berrih-Aknin, F. Adrian, P. Moreau, S. Poea, L. Gourand, J. Dausset, E. D. Carosella, and P. Paul. 2001. A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-β. J. Biol. Chem. 276: 6133-6139. (Pubitemid 37373467)
36. Ibrahim, E. C., M. Morange, J. Dausset, E. D. Carosella, and P. Paul. 2000. Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines. Cell Stress Chap. 5: 207-218.
37. Yie, S. M., R. Xiao, and C. L. Librach. 2006. Progesterone regulates HLA-G gene expression through a novel progesterone response element. Hum. Reprod. 21: 2538-2544. (Pubitemid 44542144)
38. Mouillot, G., C. Marcou, I. Zidi, C. Guillard, D. Sangrouber, E. D. Carosella, and P. Moreau. 2007. Hypoxia modulates HLA-G gene expression in tumor cells. Hum. Immunol. 68: 277-285. (Pubitemid 46509544)
39. Yang, Y., W. Chu, D. E. Geraghty, and J. S. Hunt. 1996. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ. J. Immunol. 156: 4224-4231.
40. Moreau, P., F. Adrian-Cabestre, C. Menier, V. Guiard, L. Gourand, J. Dausset, E. D. Carosella, and P. Paul. 1999. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int. Immunol. 11: 803-811.
41. Bamberger, A. M., S. Jenatschke, H. M. Schulte, T. Loning, and M. C. Bamberger. 2000. Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells. J. Clin. Endocrinol. Metab. 85: 3932-3936.
42. Amiot, L., M. Onno, B. Drenou, C. Monvoisin, and R. Fauchet. 1998. HLA-G class I gene expression in normal and malignant hematopoietic cells. Hum. Immunol. 59: 524-528. (Pubitemid 28354973)
43. Moreau, P., O. Faure, S. Lefebvre, E. C. Ibrahim, M. O'Brien, L. Gourand, J. Dausset, E. D. Carosella, and P. Paul. 2001. Glucocorticoid hormones upregulate levels of HLA-G transcripts in trophoblasts. Transplant. Proc. 33: 2277-2280.
44. Yie, S. M., L. H. Li, G. M. Li, R. Xiao, and C. L. Librach. 2006. Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro. Hum. Reprod. 21: 46-51.
45. Moreau, P., G. Mouillot, P. Rousseau, C. Marcou, J. Dausset, and E. D. Carosella. 2003. HLA-G gene repression is reversed by demethylation. Proc. Natl. Acad. Sci. USA 100: 1191-1196.
46. Mouillot, G., C. Marcou, P. Rousseau, N. Rouas-Freiss, E. D. Carosella, and P. Moreau. 2005. HLA-G gene activation in tumor cells involves cis-acting epigenetic changes. Int. J. Cancer 113: 928-936. (Pubitemid 40096872)
47. Masternak, K., A. Muhlethaler-Mottet, J. Villard, M. Zufferey, V. Steimle, and W. Reith. 2000. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14: 1156-1166. (Pubitemid 30324428)
48. Flajollet, S., B. Lefebvre, C. Cudejko, B. Staels, and P. Lefebvre. 2007. The core component of the mammalian SWI/SNF complex SMARCD3/BAF60c is a coactivator for the nuclear retinoic acid receptor. Mol. Cell. Endocrinol. 270: 23-32. (Pubitemid 46670547)
49. Zhang, L., J. Zhao, and H. J. Edenberg. 1999. A human Raf-responsive zinc-finger protein that binds to divergent sequences. Nucleic Acids Res. 27: 2947-2956. (Pubitemid 29335717)
50. Moeenrezakhanlou, A., D. Nandan, and N. E. Reiner. 2008. Identification of a calcitriol-regulated Sp-1 site in the promoter of human CD14 using a combined western blotting electrophoresis mobility shift assay (WEMSA). Biol. Proceed. Online 10: 29-35. (Pubitemid 351279850)
51. Flajollet, S., B. Lefebvre, C. Rachez, and P. Lefebvre. 2006. Distinct roles of the steroid receptor coactivator 1 and of MED1 in retinoid-induced transcription and cellular differentiation. J. Biol. Chem. 281: 20338-20348. (Pubitemid 44065808)
52. Mantovani, R. 1999. The molecular biology of the CCAAT-binding factor NF-Y. Gene 239: 15-27. (Pubitemid 29462565)
53. Thiagalingam, A., A. De Bustros, M. Borges, R. Jasti, D. Compton, L. Diamond, M. Mabry, D. W. Ball, S. B. Baylin, and B. D. Nelkin. 1996. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol. Cell Biol. 16: 5335-5345. (Pubitemid 26315052)
54. Fujimoto-Nishiyama, A., S. Ishii, S. Matsuda, J. Inoue, and T. Yamamoto. 1997. A novel zinc finger protein, Finb, is a transcriptional activator and localized in nuclear bodies. Gene 195: 267-275. (Pubitemid 27354704)
55. Ray, S. K., J. Nishitani, M. W. Petry, M. Y. Fessing, and A. B. Leiter. 2003. Novel transcriptional potentiation of BETA2/NeuroD on the secretin gene promoter by the DNA-binding protein Finb/RREB-1. Mol. Cell Biol. 23: 259-271.
56. Zhang, S., X. Qian, C. Redman, V. Bliskovski, E. S. Ramsay, D. R. Lowy, and B. A. Mock. 2003. p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene 22: 2285-2295.
57. Date, S., Y. Nibu, K. Yanai, J. Hirata, K. Yagami, and A. Fukamizu. 2004. Finb, a multiple zinc finger protein, represses transcription of the human angiotensinogen gene. Int. J. Mol. Med. 13: 637-642.
58. Mukhopadhyay, N. K., B. Cinar, L. Mukhopadhyay, M. Lutchman, A. S. Ferdinand, J. Kim, L. W. Chung, R. M. Adam, S. K. Ray, A. B. Leiter, et al. 2007. The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol. Endocrinol. 21: 2056-2070.
59. Shi, Y., J. Sawada, G. Sui, B. Affar el, J. R. Whetstine, F. Lan, H. Ogawa, M. P. Luke, and Y. Nakatani. 2003. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422: 735-738.
60. Miyake, J. H., D. P. Szeto, and W. E. Stumph. 1997. Analysis of the structure and expression of the chicken gene encoding a homolog of the human RREB-1 transcription factor. Gene 202: 177-186.
61. Gorg, A., W. Weiss, and M. J. Dunn. 2004. Current two-dimensional electrophoresis technology for proteomics. Proteomics 4: 3665-3685.
62. Ruthenburg, A. J., H. Li, D. J. Patel, and C. D. Allis. 2007. Multivalent engagement of chromatin modifications by linked binding modules. Nat. Rev. Mol. Cell Biol. 8: 983-994.
63. Chinnadurai, G. 2007. Transcriptional regulation by C-terminal binding proteins. Int. J. Biochem. Cell. Biol. 39: 1593-1607.
64. Schaeper, U., T. Subramanian, L. Lim, J. M. Boyd, and G. Chinnadurai. 1998. Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. J. Biol. Chem. 273: 8549-8552.
65. Zhao, L. J., T. Subramanian, S. Vijayalingam, and G. Chinnadurai. 2007. PLDLS-dependent interaction of E1A with CtBP: regulation of CtBP nuclear localization and transcriptional functions. Oncogene 26: 7544-7551.
66. Vo, N., C. Fjeld, and R. H. Goodman. 2001. Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol. Cell Biol. 21: 6181-6188.
67. Guillaudeux, T., A. M. Rodriguez, M. Girr, V. Mallet, S. A. Ellis, I. L. Sargent, R. Fauchet, E. Alsat, and P. Le Bouteiller. 1995. Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta. J. Immunol. 154: 3283-3299.